Table 3 The effect of 70-GS use on the administration of adjuvant CT as observed with linear mixed-effect modeling, in the overall study population (n = 2,043), guideline- and age-delineated subgroups of patients within the indicated area for 70-GS use, with and without adjustment for potential confounders

From: Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study